prismIndustries

  In today’s healthcare world, quitting smoking has become a top priority across the globe. With millions of people striving to enhance their respiratory and heart health, the need for effective nicotine replacement therapy (NRT) solutions has skyrocketed. Prism Industries Pvt. Ltd. is leading the charge in this initiative, proudly serving as a top-notch nicotine polacrilex manufacturer committed to providing high-purity ingredients that help individuals embrace a tobacco-free lifestyle. Getting to Know Nicotine Polacrilex Resinate Nicotine polacrilex resinate is a unique blend of nicotine and a carboxylic acid ion-exchange resin, usually polacrilex. This specialized formulation is crafted to deliver a controlled release of nicotine into the bloodstream. Unlike pure nicotine, which can hit the system too quickly, the resin complex ensures a steady, therapeutic level of nicotine is maintained, easing withdrawal symptoms without the harmful toxins found in tobacco smoke. As a leadin...

  The ongoing battle against malaria is one of the most pressing issues in today's healthcare landscape. At the forefront of this fight is the production of top-notch active pharmaceutical ingredients (APIs), which are essential for life-saving treatments. Prism Industries Pvt. Ltd. shines as a leader in this field, recognized as a premier lumefantrine manufacturer in India and a reliable partner for healthcare providers around the globe. The Essential Role of Lumefantrine USP Lumefantrine USP is a powerful antimalarial drug, mainly used in tandem with artemether (commonly known as Co-artemether). This combination is endorsed by the World Health Organization (WHO) as a first-line treatment for acute, uncomplicated malaria caused by Plasmodium falciparum. While artemether acts quickly to reduce the parasite load, Lumefantrine USP has a longer half-life, ensuring that any lingering parasites are eliminated from the bloodstream, thus preventing a relapse. As a leading API manufacture...

  The global challenge posed by Alzheimer’s disease has led researchers to explore new avenues beyond conventional treatments, focusing on compounds that can stabilize and boost cognitive function. One of the most exciting candidates in the field of neuro-therapeutics is nicotine bitartrate dihydrate. While it’s often linked to helping people quit smoking, this particular nicotine bitartrate API is gaining recognition for its potential to tackle the cholinergic deficit that contributes to memory loss in Alzheimer’s patients. Prism Industries Pvt. Ltd., a leading API manufacturer in India, is thrilled to supply the high-purity ingredients essential for advancing this crucial medical research. The Science of Nicotine and Cognitive Enhancement Alzheimer’s disease is characterized by the gradual deterioration of neurons, especially those that rely on acetylcholine as a neurotransmitter. This "cholinergic hypothesis" sheds light on why patients face challenges with memory, attenti...